[对于严重的额头回而言,跨septal transcatheter 额头替换的可行性和安全性]
1Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China.
Zhonghua yi xue za zhi
|June 25, 2023
概括
使用HighLife系统进行跨septal通透管中膜置换 (TSMVR) 是高手术风险患者严重中膜吐的可行且安全的选择. 这种新的方法在治疗复杂的心脏病方面显示出有希望的结果.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 严重的甲骨管反会带来重大风险,特别是在被认为具有高手术风险的患者身上.
- 过导管 mitra 置换 (TAVR) 为传统手术提供了一种不那么侵入性的替代方案.
- 跨septal方法为TAVR提供了一个新的途径,可能扩大治疗选择.
研究的目的:
- 为了评估跨septal transcatheter中枢替换 (TSMVR) 的可行性和安全性.
- 评估HighLife TSMVR系统在患有严重额头肌吐的患者中的疗效.
- 在手术后30天内识别潜在的并发症和结果.
主要方法:
- 前性,单中心,单臂,开放式设计研究.
- 招募的高手术风险患者有症状中度至重度或重度的甲骨管吐.
- 使用了HighLife的跨septal中枢替换系统.
主要成果:
- 在所有四名注册患者中都取得了技术上的成功.
- 没有观察到残留的 mitrale 吐,准膜泄漏或左心室外流通道阻塞.
- 在30天内发生了三次主要不良事件:心室低心率,阳性心房隔膜缺陷关闭和心力衰竭再入院.
结论:
- 通过HighLife系统替换交叉管中膜是初步可行的,并且对于严重的中回来说相对安全.
- 该研究强调了这种方法在高手术风险患者中的潜力.
- 需要进一步的研究来证实长期的结果和安全性.
相关概念视频
01:25Mitral Regurgitation III: Medical Management
20
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
20
01:26Mitral Stenosis III: Medical Management
14
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
26
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
26
01:28Mitral Regurgitation IV: Nursing Management
51
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
51
01:20Mitral Regurgitation I: Introduction
19
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
19
01:22Mitral Valve Prolapse II: Assessment and Management
23
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
23